T. Rowe Price Associates
LVGO

T. Rowe Price Associates’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

T. Rowe Price Associates’s Portfolio LVGO Stock Details LVGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-483,042
Closed -$67.7M – 2764
2020
Q3 		$67.7M Sell
483,042
-1,237
-0.3% -$151K 0.01% 772
2020
Q2 		$36.4M Buy
484,279
+468,768
+3,022% +$24.5M ﹤0.01% 957
2020
Q1 		$443K Buy
+15,511
New +$402K ﹤0.01% 2043

T. Rowe Price Associates's LVGO Position: Q4 2020 in Review

T. Rowe Price Associates sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 483,042 shares — an estimated $67.7M sold.

T. Rowe Price Associates first reported a position in LVGO in Q1 2020 and held it in 3 quarters. The position peaked at $67.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

  • T. Rowe Price Associates reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • T. Rowe Price Associates sold 483,042 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $67.7M.
  • T. Rowe Price Associates first reported a position in Livongo Health, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • T. Rowe Price Associates's Livongo Health, Inc. Common Stock position peaked at $67.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on T. Rowe Price Associates's 13F filing for Q4 2020, filed 16 Feb 2021.